Flora Fertility, a Calgary-based insurtech company, has successfully closed an oversubscribed pre-seed funding round, raising $1.5 million to support the launch of a private fertility insurance product across the U.S. and Canada. This initiative marks a significant step toward making fertility treatments more accessible and affordable for millions of individuals and families.
The funding round was led by Toronto’s Highline Beta and supported by co-investors such as Cartography Capital from the Bay Area, Everywhere Ventures based in New York and LA, and a strategic network of angel investors from the insurance, tech, and financial services sectors. Flora’s unique approach to fertility insurance has attracted widespread attention, signaling its potential to revolutionize fertility care.
With infertility impacting one in six individuals and treatment costs often exceeding $50,000, access to fertility services has become a critical health issue. In April 2023, the World Health Organization recognized infertility as a global health challenge, highlighting the need for innovative funding models.
Flora Fertility offers a pioneering solution: a personalized, portable fertility insurance product, allowing individuals to own their policies independently of employment. This model diverges from traditional loan-based or group offerings, offering policyholders greater control over their reproductive health, regardless of location or job status. The initial rollout will focus on women as primary policyholders, with the product available through partnerships with women’s health apps, small-to-medium-sized businesses, and other channels across North America.
“Our mission is simple: we want to make fertility care accessible and affordable for everyone,” said Laura J. McDonald, Flora Fertility’s co-founder. “This solution allows women and families to proactively protect their reproductive futures. The enthusiastic response we’ve received shows just how necessary this product is for future policyholders.”
Flora’s founding team includes Laura J. McDonald, Dr. Christy Lane, and Somil Jain, each bringing a wealth of experience in data analytics, actuarial modeling, and financial services. The company has developed the first individual risk model tailored for fertility insurance, an advancement that combines cutting-edge research with practical insurance solutions.
“No one has created an individual risk model for fertility until now,” noted Dr. Lane. “We’re leading this innovation, using our expertise in women’s health, data science, and actuarial modeling to create a solution that will change how people finance fertility treatments, especially in underserved markets.”
The launch of Flora Fertility’s insurance product is set to make waves in the industry, positioning the company as a leader in accessible fertility care while setting new standards for personalized insurance solutions.
Leave a Reply